to transform the discovery of novel drugs addressing targets in the GPCR family
to address clinical challenges critically relevant to a broad range of patients suffering from cardiovascular diseases, dysregulated inflammation, and other conditions
GPCRs whose natural ligands are peptides or proteins represent large untapped opportunities, best addressed with a biologic approach
unlocks the therapeutic utility of the most difficult receptors in the class, to date considered undruggable with small molecules
Tectonic is a privately held biotechnology company located in the Pagliuca Harvard Life Labs, in Allston, MA and led by an accomplished team of biotech and pharma industry executives.
Our founders are at the forefront of scientific research in biochemistry and molecular pharmacology, and key contributors to the development of multiple therapies for treatment of autoimmune diseases, cancer and beyond.